|
|
|
NAFLD
https://pubmed.ncbi.nlm.nih.gov/33399331/ NAFLD
J Pediatr Gastroenterol Nutr. 2020 Dec 30;Publish Ahead of Print. doi: 10.1097/MPG.0000000000003040. Online ahead of print
.
Dairy Fat Intake, Plasma C15: 0 and Plasma Iso-C17: 0 are Inversely Associated with Liver Fat in Children
Mary Catherine Sawh 1 , Martina Wallace, Emma Shapiro, Nidhi P Goyal, Kimberly P Newton, Elizabeth L Yu, Craig Bross, Janis Durelle, Cynthia Knott, Jon A Gangoiti, Bruce A Barshop, Jivani M Gengatharan, Noah Meurs, Alexandra Schlein, Michael S Middleton, Claude B Sirlin, Christian M Metallo, Jeffrey B Schwimmer
Abstract
https://pubmed.ncbi.nlm.nih.gov/33918271/ NAFLD
J Clin Med. 2021 Apr 2;10(7):1470.
doi: 10.3390/jcm10071470.
Development and Internal Validation of Fatty Liver Prediction Models in Obese Children and Adolescents
Giorgio Bedogni 1, Sofia Tamini 2, Diana Caroli 2, Sabrina Cicolini 2, Marco Domenicali 3 4, Alessandro Sartorio 2 5
Abstract
https://pubmed.ncbi.nlm.nih.gov/33894100/ NAFLD
Liver Int. 2021 Apr 24.
doi: 10.1111/liv.14908. Online ahead of print.
Diagnostic accuracy of fibrosis tests in children with Non-Alcoholic Fatty Liver Disease (NAFLD): a systematic review
Laura G Draijer 1 2 3, Janneke P M van Oosterhout 1, Yasaman Vali 4, Sabrina Zwetsloot 1, Johanna H van der Lee 5, Faridi S van Etten-Jamaludin 6, Malika Chegary 7, Marc A Benninga 1, Bart G P Koot 1
Abstract
http://www.ncbi.nlm.nih.gov/pubmed/26049712
Dincses E, Yilmaz Y. Diagnostic usefulness of FibroMeter VCTE for hepatic fibrosis in patients with nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2015 Oct; 27(10):1149-53.
Abstract
BACKGROUND:
https://pubmed.ncbi.nlm.nih.gov/33509112/ NAFLD
BMC Gastroenterol. 2021 Jan 28;21(1):41.
doi: 10.1186/s12876-021-01612-z.
Dietary patterns and risk of non-alcoholic fatty liver disease
Ammar Salehi-Sahlabadi 1, Samaneh Sadat 2, Sara Beigrezaei 3 4, Makan Pourmasomi 5, Awat Feizi 6, Reza Ghiasvand 7, Amir Hadi 8, Cain C T Clark 9, Maryam Miraghajani 10 11
Abstract
Background: Nutrition is a modifiable risk factor that plays an important role in the prevention or delaying of the onset of non-alcoholic fatty liver disease (NAFLD). Previous studies have focused on NAFLD and individual nutrients, which does not take into account combinations of food that are consumed. Therefore, we aimed to investigate the relationship between major dietary patterns and NAFLD.
https://www.ncbi.nlm.nih.gov/pubmed/30009050 NAFLD
J Obes. 2018 Jun 12;2018:8626818. doi: 10.1155/2018/8626818. eCollection 2018.Dyslipidemia and Fatty Liver Disease in Overweight and Obese Children.Deeb A1, Attia S1, Mahmoud S2, Elhaj G3, Elfatih A4.
Abstract
INTRODUCTION:
Obesity is a worldwide concern. It is associated with morbidity such as dyslipidemia and liver disease. Childhood obesity has dramatically increased, particularly in the Gulf region. We aim to assess the prevalence of dyslipidemia and fatty liver disease (FLD) in overweight and obese children and analyze the association between different anthropometric measures with dyslipidemia and fatty liverdisease.
METHODS:
https://www.ncbi.nlm.nih.gov/pubmed/29699915 NAFLD
J Clin Lipidol. 2018 Apr 3. pii: S1933-2874(18)30194-6. doi: 10.1016/j.jacl.2018.03.089. [Epub ahead of print]Dyslipidemia is associated with pediatric nonalcoholic fatty liver disease. Dowla S1, Aslibekyan S2, Goss A3, Fontaine K4, Ashraf AP5.
Abstract
BACKGROUND:
With the increasing prevalence of childhood obesity, nonalcoholic fatty liver disease (NAFLD) has emerged as the most common cause of pediatric chronic liver disorder. Factors underlying the pathophysiology of NAFLD remain poorly defined.
OBJECTIVE:
This study aimed to describe the metabolic characteristics of children with NAFLD differing in race/ethnicity and to test associations between dyslipidemia and NAFLD.
METHODS:
http://www.ncbi.nlm.nih.gov/pubmed/27417217
Lin YC, Chang PF, Lin HF, Liu K, Chang MH, Ni YH. J Hepatol. 2016 Jul 11. pii: S0168-8278(16)30330-0. doi: 10.1016/j.jhep.2016.06.029
Abstract
BACKGROUND & AIMS:
Autophagy has been shown to be crucial in the regulation of the intracellular lipid stores in hepatocytes. We hypothesize that immunity-related GTPase family M (IRGM) gene (an autophagy-related gene) variants confer the susceptibility to nonalcoholic fatty liver disease (NAFLD) development.
METHODS:
https://www.ncbi.nlm.nih.gov/pubmed/29601997
Contemp Clin Trials. 2018 Mar 27. pii: S1551-7144(17)30601-8. doi: 10.1016/j.cct.2018.03.014. [Epub ahead of print]
Effectiveness of a carbohydrate restricted diet to treat non-alcoholic fatty liverdisease in adolescents with obesity: Trial design and methodology.
Dowla S, Pendergrass M, Bolding M, Gower B, Fontaine K, Ashraf A, Soleymani T, Morrison S, Goss A.
Abstract
BACKGROUND:
Non-alcoholic fatty liver disease (NAFLD) is the most common liver disorder among children in the developed world and can progress to cirrhosis, hepatocellular carcinoma, and liver failure. No evidence-based dietary guidelines exist on the most effective diet prescription to treat NAFLD.
OBJECTIVE:
https://www.ncbi.nlm.nih.gov/pubmed/29201174 NAFLD
Exp Ther Med. 2017 Nov;14(5):4737-4744. doi: 10.3892/etm.2017.5128. Epub 2017 Sep 19.
Zhou H, Shi T, Yan J, Chen X, Liao L, Zhao S, Fang H, Zhuang R.
Abstract
SMS requests to
9224791366
Ask The Expert
Pediatric Liver Specialists in India
Centres offering Genetic Testing for Pediatric Liver Diseases
Financial Aid Offered by Trusts
